144 related articles for article (PubMed ID: 33445214)
1. Prognostic significance of atypical mitotic figures in smooth muscle tumors of uncertain malignant potential (STUMP) of the uterus and uterine adnexa.
Travaglino A; Raffone A; Santoro A; Gencarelli A; Angelico G; Spadola S; Marzullo L; Zullo F; Insabato L; Zannoni GF
APMIS; 2021 Apr; 129(4):165-169. PubMed ID: 33445214
[TBL] [Abstract][Full Text] [Related]
2. Stanford parameters stratify the risk of recurrence in gynecologic smooth muscle tumors of uncertain malignant potential.
Travaglino A; Raffone A; Gencarelli A; Caldarelli C; Granata M; Santoro A; Zannoni GF; Mollo A; Zullo F; Insabato L
APMIS; 2021 Jun; 129(6):283-290. PubMed ID: 33786917
[TBL] [Abstract][Full Text] [Related]
3. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
Ip PP; Cheung AN; Clement PB
Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
[TBL] [Abstract][Full Text] [Related]
4. Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.
Pang SJ; Li CC; Shen Y; Liu YZ; Shi YQ; Liu YX
Int J Clin Exp Pathol; 2015; 8(5):4418-26. PubMed ID: 26191133
[TBL] [Abstract][Full Text] [Related]
5. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
[TBL] [Abstract][Full Text] [Related]
6. [Reappraisal of the pathological criteria for uterine leiomyosarcoma].
Guo L; Liu T; Huang H
Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):266-9. PubMed ID: 9388868
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.
Ünver NU; Acikalin MF; Öner Ü; Ciftci E; Ozalp SS; Colak E
Arch Gynecol Obstet; 2011 Aug; 284(2):483-90. PubMed ID: 20878171
[TBL] [Abstract][Full Text] [Related]
8. [Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].
Shi YF; Xie X; Zhao CL
Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):201-4, 251. PubMed ID: 8082439
[TBL] [Abstract][Full Text] [Related]
9. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
Bell SW; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
11. p53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP).
Travaglino A; Raffone A; Gencarelli A; Neola D; Oliviero DA; Alfano R; Campanino MR; Cariati F; Zullo F; Mollo A; Insabato L
Pathol Res Pract; 2021 Oct; 226():153592. PubMed ID: 34481212
[TBL] [Abstract][Full Text] [Related]
12. Predictors of adverse outcome in uterine smooth muscle tumours of uncertain malignant potential (STUMP): a clinicopathological analysis of 22 cases with a proposal for the inclusion of additional histological parameters.
Gupta M; Laury AL; Nucci MR; Quade BJ
Histopathology; 2018 Aug; 73(2):284-298. PubMed ID: 29537683
[TBL] [Abstract][Full Text] [Related]
13. Smooth Muscle Tumors of the Visceral Adnexal and Uterine Ligaments and Adnexal Connective Tissue: A Clinicopathologic Study of 67 Cases.
Patel V; Xing D; Feely M; Schoolmeester JK
Int J Gynecol Pathol; 2020 Jan; 39(1):55-67. PubMed ID: 30702465
[TBL] [Abstract][Full Text] [Related]
14. STUMP - atypowy mięśniak macicy - mimikra guza złośliwego?
Ropacka-Lesiak M; Suminska M; Jasiński P; Podkowa N; Bręborowicz GH
Ginekol Pol; 2016; 87(2):148-52. PubMed ID: 27306293
[TBL] [Abstract][Full Text] [Related]
15. Fascin expression in uterine smooth muscle tumors.
Kefeli M; Yildiz L; Kaya FC; Aydin O; Kandemir B
Int J Gynecol Pathol; 2009 Jul; 28(4):328-33. PubMed ID: 19483633
[TBL] [Abstract][Full Text] [Related]
16. [Uterine fibroid associated with smooth muscle tumor of uncertain malignant potential (STUMP): about a case].
Saoud MK; Benchiba I; Mamouni N; Errarhay S; Bouchikhi C; Banani A
Pan Afr Med J; 2018; 31():151. PubMed ID: 31086612
[TBL] [Abstract][Full Text] [Related]
17. Risk of Recurrence in Uterine Leiomyoma with Bizarre Nuclei: a Systematic Review and Meta-Analysis.
Travaglino A; Raffone A; Santoro A; Raimondo D; Improda FP; Cariati F; De Marco M; Casadio P; Seracchioli R; Zullo F; Insabato L; Zannoni GF
Geburtshilfe Frauenheilkd; 2021 Nov; 81(11):1217-1223. PubMed ID: 34754271
[No Abstract] [Full Text] [Related]
18. Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis.
Amant F; Moerman P; Vergote I
Int J Gynecol Cancer; 2005; 15(6):1210-2. PubMed ID: 16343216
[TBL] [Abstract][Full Text] [Related]
19. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous leiomyoma with cytologic atypia, akin to uterine symplastic leiomyoma.
Matthews JH; Pichardo RO; Hitchcock MG; Leshin B
Dermatol Surg; 2004 Sep; 30(9):1249-51; discussion 1251. PubMed ID: 15355371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
